申请人:Incyte Corporation
公开号:US20140171405A1
公开(公告)日:2014-06-19
The present invention relates to fused pyrazole derivatives, and pharmaceutical compositions including the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
本发明涉及融合吡唑衍生物,以及包括这些衍生物的药物组合物,这些衍生物是一种或多种FGFR酶的抑制剂,并且在治疗FGFR相关疾病如癌症方面具有用处。